Rheumatoid Arthritis Treatment Market to be Dominated by Growing Technological Advancements in United Kingdom Through 2028
Collaboration
and partnerships between renowned pharmaceutical industries of United Kingdom
and growing rate of obesity are the major growth drivers for the United Kingdom rheumatoid
arthritis treatment market.
According
to TechSci Research report, “United Kingdom Rheumatoid Arthritis Treatment Market
–By Region, Competition, Forecast and Opportunities, 2028F”, the United Kingdom Rheumatoid
Arthritis Treatment market is anticipated to register a high CAGR during the
forecast period. This can be ascribed to the development of medical tourism in
United Kingdom. Growing mergers and acquisitions among leading
pharmaceutical companies of United Kingdom with an approach of combing
distinctive expertise of individual companies and developing novel treatment method
for rheumatoid arthritis, is expected to register an impressive growth to
United Kingdom rheumatoid arthritis treatment market in the forecast period. For
instance, GlaxoSmithKline plc. has acquired Pfizer's consumer healthcare
business in a joint venture deal worth approximately $12.7 billion. This
acquisition has enabled GlaxoSmithKline plc. to strengthen its position in the
consumer healthcare market. Growing technological advancements in
pharmaceutical industries for increasing the accuracy of treatment for
rheumatoid arthritis is also expected to propel the growth of United Kingdom rheumatoid arthritis treatment market in
the forecast period. Auto-antibodies play a pivotal clinical role in patients
with systemic rheumatoid arthritis. Recent advancements in usage of
auto-antibodies as biomarkers have assisted in efficient diagnosis, prognosis,
and treatment decision of rheumatoid arthritis. Moreover, use of multiple
medications in combination, such as DMARDs and biologics, have provided a new
approach for different mechanisms of action to target inflammation from various
angles.
Growing rate of obesity among developing countries of United Kingdom
due to adoption of sedentary habits by people such as consumption of unhealthy
diet and physical inactivity, is another one of the significant factors
propelling the growth of United Kingdom rheumatoid arthritis treatment market
during the forecast period. As per the analysis made by government of United
Kingdom on obesity in 2022, it has been observed that approximately 29.5% of
people aged 45-54 years of age are obese, 30.2% of people aged between 55-64
years are obese, 29.1% of people aged between 65-74 years are obese, 26.1%
people between age of 75-84 years are obese and so on. Obesity increases
the risk and severity of rheumatoid arthritis by contributing to a chronic
state of low-grade inflammation in the body.
In individuals with a genetic
predisposition to rheumatoid arthritis, excess weight and obesity can further
enhance the inflammatory response. Growing medical tourism of United Kingdom
due to state-of-the-art orthopedic and rheumatology services provided by
healthcare professionals, is indeed one of the prominent factors expected to
register an impressive growth to United Kingdom Rheumatoid Arthritis Treatment
market during the forecast period. For instance, Dual-Energy X-ray
Absorptiometry (DEXA) scanning used by rheumatologists in UK for measuring bone
mineral density in treatment of osteoporosis, has influenced a lot of people
from outer countries regarding treatment of rheumatoid arthritis disorder.
Moreover, revenue generated from growth in medical tourism of the countries is
also supporting the market growth.
However, cost limitations on existing treatment
options and limited insurance coverage are expected to slow down the growth of
the market in the coming years.
Browse
over XX market data Figures and spread through XX
Pages and an in-depth TOC on " United Kingdom Rheumatoid ArthritisTreatment Market.”
The United Kingdom Rheumatoid Arthritis Treatment
market segmentation is based on Treatment Type, End User, By Company, and
Region.
Based on End User, the market is further divided into
Hospital & clinics, Ambulatory Care Centers, and Other. Hospital & Clinics
segment is likely to dominate the market in the forecast period. This can be attributed to the ease in availability and
accessibility of medications in United Kingdom required for the treatment of
rheumatoid arthritis.
Some
of the major companies operating in the United Kingdom Rheumatoid
Arthritis Treatment Market include:
- Medtronic Ltd.
- 3M United Kingdom Public Limited
- ConvaTec, Inc.
- Smith & Nephew plc.
- B. Braun Medical Ltd.
- Mölnlycke Health Care Limited
- Novartis Pharmaceuticals UK Ltd.
- GlaxoSmithKline plc.
- AbbVie Ltd.
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“Certain
regions are expected to dominate the demand for rheumatoid arthritis treatment in
United Kingdom. Presence of well-established pharmaceutical companies in the
market who are coming up with innovations in therapeutic products for effective
management of rheumatoid arthritis along with development of novel treatment
strategies, are expected to register a lucrative growth to United Kingdom
Rheumatoid Arthritis Treatment Market in the forecast period," said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based global management
consulting firm.
United
Kingdom Rheumatoid Arthritis Treatment Market By
Treatment Type (Symptomatic Treatment, Intermediate Corticosteroid Therapies,
Stem Cell Therapies, Drugs (Disease-modifying Anti-Rheumatic Drugs (DMARDs),
Nonsteroidal Anti-inflammatory Drugs (NSAIDS), Corticosteroids, Uric Acid
Drugs, Others), Others), By End User (Hospital & clinics, Ambulatory Care
Centers, Other), By Region & Competition, Forecast & Opportunities, 2018-2028F has evaluated the future
growth potential of United Kingdom Rheumatoid Arthritis Treatment Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in United Kingdom Rheumatoid Arthritis Treatment market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com